VisionSort: A New Dimension in Cell Analysis & Sorting
VisionSort: A New Dimension in Cell Analysis & Sorting (JPN/日本語)
Watch: VisionSort: Applications in Stem Cell R&D Webinar
VisionSort: Applications in Stem Cell R&D Webinar
Learn more about VisionSort applications in stem cell R&D and regenerative medicine. Highlights include applications in induced pluripotent stem cells (iPSC), human mesenchymal stem cells (hMSC), and progenitor cells. Combining gentle microfluidics based sorting that maintains stem cell viability and differentiation potential with sensitive, label-free isolation of specific cell phenotypes, VisionSort is uniquely positioned to address fundamental challenges in stem cell R&D and regenerative medicine.
Ghost Cytometry Explained in 2 minutes
Introduction to the VisionSort Platform
Introduction to the VisionSort Platform (JPN/日本語)
Characterization and label-free isolation of phenotypically defined human immune cells using Ghost Cytometry
VisionSort Technical Specifications
VisionSort Brochure
VisionSort Brochure (JPN/日本語)
Label Free Detection of Subtle Morphological Differences in Immune Cells
Classification of Cellular Diversity and Disease Assessment in ALL
Acute Lymphoblastic Leukemia (ALL) is a malignancy of lymphoid progenitor cells in the bone marrow and blood. The disease has a bimodal distribution with 80% of ALL patients presenting as children who respond positively to therapy. However, for adult patients ALL can be a devastating disease, with only 30–40% achieving long–term remission. Chromosomal abnormalities, such as the Philadelphia chromosome, are commonly found in ALL and are a major determinant of prognostic outcome. While long-term survival in pediatric ALL without chromosomal abnormalities approaches 90%, Philadelphia chromosome positive adult ALL has a five-year survival rate of 5 – 20%. As research into the genomic determinants of ALL disease progression and response to […]
